Press Releases and Events
PRESS RELEASES
Press Release | March 30, 2021
2021 Clinical Plans, 4th Quarter, and 2020 Financial Results
READ MORE
Press Release | March 24, 2021
Webcast: 2021 Clinical Plans and Fourth Quarter and Full Year 2020 Financial Results
READ MORE
Press Release | March 22, 2021
Crinetics Pharmaceuticals Pipeline Progress on Display at ENDO 2021
READ MORE
Press Release | February 4, 2021
Lead ACTH Antagonist CRN04894 (Cushing's, CAH) Enters Phase 1 Study
READ MORE
Press Release | February 3, 2021
CRN04777 (Congenital Hyperinsulinism) Advances to Phase 1 Study
READ MORE
Press Release | January 6, 2021
Crinetics Announces 2021 Plans at J.P. Morgan Healthcare Conference
READ MORE
Press Release | November 23, 2020
Crinetics Pharmaceuticals to Participate in December Investor Conferences
READ MORE
WEBCAST
PRESS RELEASETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
